163 related articles for article (PubMed ID: 37790812)
1. G. lucidum triterpenes restores intestinal flora balance in non-hepatitis B virus-related hepatocellular carcinoma: evidence of 16S rRNA sequencing and network pharmacology analysis.
Xiong W; Yang C; Xia J; Wang W; Li N
Front Pharmacol; 2023; 14():1197418. PubMed ID: 37790812
[No Abstract] [Full Text] [Related]
2. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
Li S; Hao L; Hu X; Li L
Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
[TBL] [Abstract][Full Text] [Related]
3. A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma.
Fan T; Chen X; Yang F; Li Y; Gao Q; Li S; Chen X; Chen X
J Clin Transl Res; 2023 Jun; 9(3):182-194. PubMed ID: 37275579
[TBL] [Abstract][Full Text] [Related]
4. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
Yin X; Li J; Hao Z; Ding R; Qiao Y
Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
7. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
[TBL] [Abstract][Full Text] [Related]
8. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
9. Anticancer effect of triterpenes from
Qu L; Li S; Zhuo Y; Chen J; Qin X; Guo G
Oncol Lett; 2017 Dec; 14(6):7467-7472. PubMed ID: 29344190
[No Abstract] [Full Text] [Related]
10. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
[TBL] [Abstract][Full Text] [Related]
11. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
12. Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (
Yu Y; Ding S; Xu X; Yan D; Fan Y; Ruan B; Zhang X; Zheng L; Jie W; Zheng S
Drug Des Devel Ther; 2023; 17():659-673. PubMed ID: 36883114
[TBL] [Abstract][Full Text] [Related]
13. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
[TBL] [Abstract][Full Text] [Related]
15. Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of
Xu W; Jiang Y; Tao J; Liu Y; Xia Y; Chen C; Jiang X
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37338093
[No Abstract] [Full Text] [Related]
16. Exploring the mechanisms underlying the therapeutic effect of the
Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
[TBL] [Abstract][Full Text] [Related]
17. Regulatory effect of
Qin X; Fang Z; Zhang J; Zhao W; Zheng N; Wang X
Front Microbiol; 2024; 15():1362479. PubMed ID: 38572237
[TBL] [Abstract][Full Text] [Related]
18. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
PeerJ; 2019; 7():e7408. PubMed ID: 31392101
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two officinal Chinese pharmacopoeia species of Ganoderma based on chemical research with multiple technologies and chemometrics analysis.
Da J; Wu WY; Hou JJ; Long HL; Yao S; Yang Z; Cai LY; Yang M; Jiang BH; Liu X; Cheng CR; Li YF; Guo DA
J Chromatogr A; 2012 Jan; 1222():59-70. PubMed ID: 22226558
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
Zhao RL; He YM
J Ethnopharmacol; 2018 Jan; 210():287-295. PubMed ID: 28882624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]